Valeant seeks to buy Cephalon for $5.7 billion - Reuters

vlastaowibopaj.blogspot.com

Valeant seeks to buy Cephalon for $5.7 billion Reuters NEW YORK (Reuters) - Canadian drugmaker Valeant Pharmaceuticals International said it has made an unsolicited $5.7 billion bid to buy Cephalon Inc that it expects to finance entirely with debt. Valeant, formed when Canada's Biovail bought US-based ... and more »